Related references
Note: Only part of the references are listed.Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport
Wenmin Yuan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins
Maria Fawaz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
Advances in HDL: Much More than Lipid Transporters
Soumaya Ben-Aicha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cholesterol crystals and atherosclerosis
Yvonne Baumer et al.
EUROPEAN HEART JOURNAL (2020)
Time-Dependent Cardiovascular Treatment Benefit Model for Lipid-Lowering Therapies
Irfan Khan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Recent advances in the treatment of Niemann pick disease type C: A mini-review
Adrian Matencio et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Nadia Bouabdallaoui et al.
EUROPEAN HEART JOURNAL (2020)
Hydroxypropyl-β-cyclodextrin causes massive damage to the developing auditory and vestibular system
Dalian Ding et al.
HEARING RESEARCH (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cyclodextrins: Potential therapeutics against atherosclerosis
Maryam Mahjoubin-Tehran et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
Nathalie Niyonzima et al.
EBIOMEDICINE (2020)
Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
Shifa Jebari-Benslaiman et al.
BIOMEDICINES (2020)
A systematic review of the biodistribution of biomimetic high-density lipoproteins in mice
Dennis Pedersbaek et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Nadia Bouabdallaoui et al.
EUROPEAN HEART JOURNAL (2020)
Incidence, factors, and clinical significance of cholesterol crystals in coronary plaque: An optical coherence tomography study
Kazuhiro Fujiyoshi et al.
ATHEROSCLEROSIS (2019)
Ultramorphological analysis of plaque advancement and cholesterol crystal formation in Ldlr knockout mouse atherosclerosis
Yvonne Baumer et al.
ATHEROSCLEROSIS (2019)
Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin
Judit Varadi et al.
BIOMOLECULES (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants
Nelson Wang et al.
Lancet Diabetes & Endocrinology (2019)
Extracellular Lipids Accumulate in Human Carotid Arteries as Distinct Three-Dimensional Structures and Have Proinflammatory Properties
Satu Lehti et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Cholesterol Crystal-Mediated Inflammation Is Driven by Plasma Membrane Destabilization
Fei Shu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression
Yanhong Guo et al.
EBIOMEDICINE (2018)
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial A Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA CARDIOLOGY (2018)
Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization
Jie Tang et al.
JOURNAL OF LIPID RESEARCH (2017)
Cholesterol crystal as a new feature of coronary vulnerable plaques: An optical coherence tomography study
Satoshi Nishimura et al.
JOURNAL OF CARDIOLOGY (2017)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond
Peter Libby
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cholesterol crystal depth in coronary atherosclerotic plaques: A novel index of plaque vulnerability using optical frequency domain imaging
Masahiro Koide et al.
PLOS ONE (2017)
Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk
Mark A. Crumling et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Frequency of Cholesterol Crystals in Culprit Coronary Artery Aspirate During Acute Myocardial Infarction and Their Relation to Inflammation and Myocardial Injury
George S. Abela et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque
Abed Janoudi et al.
EUROPEAN HEART JOURNAL (2016)
Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: An optical coherence tomography study
Jiannan Dai et al.
ATHEROSCLEROSIS (2016)
Cholesterol crystals activate Syk and PI3 kinase in human macrophages and dendritic cells
Emma M. Corr et al.
ATHEROSCLEROSIS (2016)
High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation
Seth G. Thacker et al.
IMMUNOLOGY (2016)
Therapeutic applications of reconstituted HDL: When structure meets function
Maryam Darabi et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
Sebastian Zimmer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder
Anna Brown et al.
SCIENTIFIC REPORTS (2016)
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production
Yanhong Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties
Anna Schwendeman et al.
JOURNAL OF LIPID RESEARCH (2015)
Cholesterol Crystals Associate With Coronary Plaque Vulnerability In Vivo
Yu Kataoka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Annika Warnatsch et al.
SCIENCE (2015)
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2014)
Cholesterol crystal-induced endothelial cell activation is complement-dependent and mediated by TNF
Stig Nymo et al.
IMMUNOBIOLOGY (2014)
A Novel Mouse Model of Atherosclerotic Plaque Instability for Drug Testing and Mechanistic/Therapeutic Discoveries Using Gene and MicroRNA Expression Profiling
Yung-Chih Chen et al.
CIRCULATION RESEARCH (2013)
Mouse models of plaque rupture
Tetsuya Matoba et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2013)
Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein
Anh Hoang et al.
EUROPEAN HEART JOURNAL (2012)
Hearing Loss and Hair Cell Death in Mice Given the Cholesterol-Chelating Agent Hydroxypropyl-β-Cyclodextrin
Mark A. Crumling et al.
PLOS ONE (2012)
Plaque Rupture and Thrombosis Are Reduced by Lowering Cholesterol Levels and Crystallization With Ezetimibe and Are Correlated With Fluorodeoxyglucose Positron Emission Tomography
Roshan Patel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation
George S. Abela
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies
Raphael Zidovetzki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53
JH von der Thüsen et al.
CIRCULATION (2002)
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL
XH Xu et al.
CIRCULATION (2001)
Share Paper
